Skip to main content
Erschienen in: Surgical Endoscopy 5/2020

29.07.2019 | 2019 SAGES Oral

Predicting venous thrombosis in patients undergoing elective splenectomy

verfasst von: Peter Szasz, Ali Ardestani, Brent T. Shoji, David C. Brooks, Ali Tavakkoli

Erschienen in: Surgical Endoscopy | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Venous thrombosis (VT) is an ongoing problem for patients undergoing elective splenectomy. There is limited data evaluating risk factors for VTs. An increase in platelet counts is commonly seen after splenectomy; however, there is a paucity of literature evaluating post-operative platelet counts as a risk factor for VTs in this patient cohort. The objective of this study was to determine the incidence of VT events and to use the platelet count as a predictor for VT development.

Methods

A retrospective review was undertaken at Brigham Women’s Hospital, evaluating elective splenectomy patients between 1997 and 2018. Descriptive statistics were utilized to determine the incidence of VTs. Receiver operator characteristic (ROC) curves were utilized to identify platelet counts that could predict VTs.

Results

Five hundred and twenty splenectomies were included in the study of which 344 were completed in an open manner and 176 were done laparoscopically. The overall incidence of VT events was 6.7% (35/520), 6.1% (21/344) for open, and 8.0% (14/176) for laparoscopic approaches (p = 0.43). ROC curves demonstrated platelet counts to be a good predictor for the development of VTs with an area under the curve (AUC) of 0.77 (95% CI 0.69–0.86; p < 0.001) for all splenectomy patients, 0.70 (95% CI 0.59–0.81; p < 0.001) for those completed in an open manner, and 0.88 (95% CI 0.77–0.99; p < 0.001) for those done laparoscopically. The optimal platelet cutoff was found to be 545 for the overall splenectomy cohort, 457 for the open, and 659 for the laparoscopic cohorts. These platelet counts had a diagnostic accuracy that ranged from 61 to 86% and a negative predictive value (NPV) that ranged from 97 to 99%.

Conclusion

These results suggest platelet cutoffs that predict VTs. This information can be used to individualize prophylactic strategies.
Literatur
1.
Zurück zum Zitat Maurus CF, Schafer M, Muller MK, Clavien PA, Weber M (2008) Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg 32:2444–2449CrossRef Maurus CF, Schafer M, Muller MK, Clavien PA, Weber M (2008) Laparoscopic versus open splenectomy for nontraumatic diseases. World J Surg 32:2444–2449CrossRef
2.
Zurück zum Zitat Shin RD, Lis R, Levergood NR, Brooks DC, Shoji BT, Tavakkoli A (2019) Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear. Surg Endosc 33:1298–1303CrossRef Shin RD, Lis R, Levergood NR, Brooks DC, Shoji BT, Tavakkoli A (2019) Laparoscopic versus open splenectomy for splenomegaly: the verdict is unclear. Surg Endosc 33:1298–1303CrossRef
3.
Zurück zum Zitat Musallam KM, Khalife M, Sfeir PM, Faraj W, Safadi B, Abi Saad GS, Abiad F, Hallal A, Alwan MB, Peyvandi F, Jamali FR (2013) Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 257:1116–1123CrossRef Musallam KM, Khalife M, Sfeir PM, Faraj W, Safadi B, Abi Saad GS, Abiad F, Hallal A, Alwan MB, Peyvandi F, Jamali FR (2013) Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 257:1116–1123CrossRef
4.
Zurück zum Zitat Bagrodia N, Button AM, Spanheimer PM, Belding-Schmitt ME, Rosenstein LJ, Mezhir JJ (2014) Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 149:1022–1029CrossRef Bagrodia N, Button AM, Spanheimer PM, Belding-Schmitt ME, Rosenstein LJ, Mezhir JJ (2014) Morbidity and mortality following elective splenectomy for benign and malignant hematologic conditions: analysis of the American College of Surgeons National Surgical Quality Improvement Program data. JAMA Surg 149:1022–1029CrossRef
5.
Zurück zum Zitat Cadili A, de Gara C (2008) Complications of splenectomy. Am J Med 121:371–375CrossRef Cadili A, de Gara C (2008) Complications of splenectomy. Am J Med 121:371–375CrossRef
6.
Zurück zum Zitat Krauth MT, Lechner K, Neugebauer EA, Pabinger I (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention—an unresolved issue. Haematologica 93:1227–1232CrossRef Krauth MT, Lechner K, Neugebauer EA, Pabinger I (2008) The postoperative splenic/portal vein thrombosis after splenectomy and its prevention—an unresolved issue. Haematologica 93:1227–1232CrossRef
7.
Zurück zum Zitat Kimmig LM, Palevsky HI (2016) Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13:945–954CrossRef Kimmig LM, Palevsky HI (2016) Review of the association between splenectomy and chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 13:945–954CrossRef
8.
Zurück zum Zitat Montoro-Garcia S, Schindewolf M, Stanford S, Larsen OH, Thiele T (2016) The role of platelets in venous thromboembolism. Semin Thromb Hemost 42:242–251CrossRef Montoro-Garcia S, Schindewolf M, Stanford S, Larsen OH, Thiele T (2016) The role of platelets in venous thromboembolism. Semin Thromb Hemost 42:242–251CrossRef
9.
Zurück zum Zitat Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241:208–216CrossRef Ikeda M, Sekimoto M, Takiguchi S, Kubota M, Ikenaga M, Yamamoto H, Fujiwara Y, Ohue M, Yasuda T, Imamura H, Tatsuta M, Yano M, Furukawa H, Monden M (2005) High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg 241:208–216CrossRef
10.
Zurück zum Zitat Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Medica 26:297–307CrossRef Habibzadeh F, Habibzadeh P, Yadollahie M (2016) On determining the most appropriate test cut-off value: the case of tests with continuous results. Biochem Medica 26:297–307CrossRef
11.
Zurück zum Zitat Unal I (2017) Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017:3762651CrossRef Unal I (2017) Defining an optimal cut-point value in ROC analysis: an alternative approach. Comput Math Methods Med 2017:3762651CrossRef
12.
Zurück zum Zitat Koshenkov VP, Nemeth ZH, Carter MS (2012) Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 203:517–522CrossRef Koshenkov VP, Nemeth ZH, Carter MS (2012) Laparoscopic splenectomy: outcome and efficacy for massive and supramassive spleens. Am J Surg 203:517–522CrossRef
13.
Zurück zum Zitat Fraser SA, Bergman S, Garzon J (2012) Laparoscopic splenectomy: learning curve comparison between benign and malignant disease. Surg Innov 19:27–32CrossRef Fraser SA, Bergman S, Garzon J (2012) Laparoscopic splenectomy: learning curve comparison between benign and malignant disease. Surg Innov 19:27–32CrossRef
14.
Zurück zum Zitat Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141:663–669CrossRef Stamou KM, Toutouzas KG, Kekis PB, Nakos S, Gafou A, Manouras A, Krespis E, Katsaragakis S, Bramis J (2006) Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg 141:663–669CrossRef
15.
Zurück zum Zitat Harris W, Marcaccio M (2005) Incidence of portal vein thrombosis after laparoscopic splenectomy. Can J Surg 48:352–354PubMedPubMedCentral Harris W, Marcaccio M (2005) Incidence of portal vein thrombosis after laparoscopic splenectomy. Can J Surg 48:352–354PubMedPubMedCentral
16.
Zurück zum Zitat Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z (2009) Postsplenectomy reactive thrombocytosis. Proceedings 22:9–12 Khan PN, Nair RJ, Olivares J, Tingle LE, Li Z (2009) Postsplenectomy reactive thrombocytosis. Proceedings 22:9–12
17.
Zurück zum Zitat Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD (1994) Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 96:247–253CrossRef Buss DH, Cashell AW, O’Connor ML, Richards F 2nd, Case LD (1994) Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 96:247–253CrossRef
18.
Zurück zum Zitat Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost 12:1776–1787CrossRef Undas A, Brummel-Ziedins K, Mann KG (2014) Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J Thromb Haemost 12:1776–1787CrossRef
19.
Zurück zum Zitat Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38:785–791PubMed Koupenova M, Kehrel BE, Corkrey HA, Freedman JE (2017) Thrombosis and platelets: an update. Eur Heart J 38:785–791PubMed
20.
Zurück zum Zitat Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907CrossRef Khorana AA, Kuderer NM, Culakova E, Lyman GH, Francis CW (2008) Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 111:4902–4907CrossRef
21.
Zurück zum Zitat Jensvoll H, Blix K, Braekkan SK, Hansen JB (2014) Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study. PloS ONE 9:e92011CrossRef Jensvoll H, Blix K, Braekkan SK, Hansen JB (2014) Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study. PloS ONE 9:e92011CrossRef
22.
Zurück zum Zitat Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000). Lancet 355:1295–1302 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial (2000). Lancet 355:1295–1302
23.
Zurück zum Zitat Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, Investigators A (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987CrossRef Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J, Investigators A (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367:1979–1987CrossRef
24.
Zurück zum Zitat Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, Investigators W (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959–1967CrossRef Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P, Investigators W (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366:1959–1967CrossRef
25.
Zurück zum Zitat Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S–e277SCrossRef Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM (2012) Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141:e227S–e277SCrossRef
Metadaten
Titel
Predicting venous thrombosis in patients undergoing elective splenectomy
verfasst von
Peter Szasz
Ali Ardestani
Brent T. Shoji
David C. Brooks
Ali Tavakkoli
Publikationsdatum
29.07.2019
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 5/2020
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-019-07007-2

Weitere Artikel der Ausgabe 5/2020

Surgical Endoscopy 5/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.